Cargando…
The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390877/ https://www.ncbi.nlm.nih.gov/pubmed/30806705 http://dx.doi.org/10.1093/rheumatology/key280 |
| _version_ | 1783398221097205760 |
|---|---|
| author | Tanaka, Yoshiya |
| author_facet | Tanaka, Yoshiya |
| author_sort | Tanaka, Yoshiya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6390877 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63908772019-03-04 The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases? Tanaka, Yoshiya Rheumatology (Oxford) Editorial Oxford University Press 2019-02 2019-02-26 /pmc/articles/PMC6390877/ /pubmed/30806705 http://dx.doi.org/10.1093/rheumatology/key280 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Editorial Tanaka, Yoshiya The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases? |
| title | The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases? |
| title_full | The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases? |
| title_fullStr | The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases? |
| title_full_unstemmed | The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases? |
| title_short | The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases? |
| title_sort | jak inhibitors: do they bring a paradigm shift for the management of rheumatic diseases? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390877/ https://www.ncbi.nlm.nih.gov/pubmed/30806705 http://dx.doi.org/10.1093/rheumatology/key280 |
| work_keys_str_mv | AT tanakayoshiya thejakinhibitorsdotheybringaparadigmshiftforthemanagementofrheumaticdiseases AT tanakayoshiya jakinhibitorsdotheybringaparadigmshiftforthemanagementofrheumaticdiseases |